At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
OPNT Opiant Pharmaceuticals, Inc.
Halted 03-01 16:00:00 EST
20.65
+0.00
0.00%
High20.65
Low20.65
Vol0.00
Open20.65
D1 Closing20.65
Amplitude0.00%
Mkt Cap108.80M
Tradable Cap92.16M
Total Shares5.27M
T/O11.63M
T/O Rate0.00%
Tradable Shares4.46M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
UPDATE 1-US FDA approves Opiant's spray for reversing opioid-related overdoses
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.